Biotage AB (Sweden) Today
| BIOT Stock | SEK 151.80 0.10 0.07% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Biotage AB is selling for under 151.80 as of the 29th of November 2024; that is 0.07 percent increase since the beginning of the trading day. The stock's last reported lowest price was 150.1. Biotage AB has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Biotage AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of May 2023 and ending today, the 29th of November 2024. Click here to learn more.
Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. The company has 65.98 M outstanding shares. More on Biotage AB
Moving together with Biotage Stock
Moving against Biotage Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biotage Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biotage AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biotage AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Life Sciences Tools & Services, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Biotage AB (BIOT) is traded on Stockholm Exchange in Sweden and employs 510 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotage AB's market, we take the total number of its shares issued and multiply it by Biotage AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biotage AB operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 65.98 M outstanding shares.
Biotage AB has accumulated about 311 M in cash with 353 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Check Biotage AB Probability Of Bankruptcy
Ownership AllocationBiotage AB holds a total of 65.98 Million outstanding shares. Over half of Biotage AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Biotage AB. Please watch out for any change in the institutional holdings of Biotage AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biotage Ownership Details
Biotage AB Risk Profiles
Although Biotage AB's alpha and beta are two of the key measurements used to evaluate Biotage AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.54 | |||
| Standard Deviation | 2.0 | |||
| Variance | 4.02 | |||
| Risk Adjusted Performance | (0.13) |
Biotage Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biotage AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Biotage AB Corporate Management
Elected by the shareholders, the Biotage AB's board of directors comprises two types of representatives: Biotage AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotage. The board's role is to monitor Biotage AB's management team and ensure that shareholders' interests are well served. Biotage AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotage AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tomas Blomquist | CEO Pres | Profile | |
| Raffaella Bombarda | EVP Marketing | Profile | |
| Maja Nilsson | Chief Officer | Profile | |
| CS BSc | Ex Operations | Profile | |
| JonSverre Schanche | Chief Officer | Profile | |
| Olof Nord | Exec Devel | Profile | |
| Lars LLB | Chief Officer | Profile |
Additional Tools for Biotage Stock Analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.